Novo Nordisk News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

09.01.18	Ozempic® approved in Canada for the treatment of adults with type 2 diabetes (PR Newswire)
09.01.18	Ozempic® approuvé au Canada pour le traitement des adultes atteints de diabète de type 2 (PR Newswire)
08.01.18	Novo Nordisk Urges Ablynx To Consider EUR 2.6 Bln Offer (RTTNews)
07.01.18	New Drugs Approved In December (RTTNews)
19.12.17	Saguenay families will enjoy improved community and outdoor spaces for a better quality of life (PR Newswire)
07.12.17	Ehave Announces Deployment of Machine Learning to Deliver Patient Insights for Mental Healthcare and Medical Cannabis (PR Newswire)
06.12.17	NVO Gets FDA Nod, GALT Down But Not Out, BIOC Gets A Boost, CUR Excited (RTTNews)
04.12.17	TAPCO Announces New Location in White Bear Lake, Minnesota (PR Newswire)
30.11.17	Phase III STRIVE study data for erenumab (AMG334) in migraine prevention published in The New England Journal of Medicine(1) (PR Newswire)
29.11.17	Biotech Stocks Facing FDA Decision In December (RTTNews)
27.11.17	Forum des communautés forestières - La FQM dévoile sa note économique pour développer les économies de la forêt (PR Newswire)
25.11.17	How the CFO of a $12 Billion Biotech Startup Eliminated the Frustrations of Lab Procurement through Procurify (PR Newswire)
24.11.17	IIROC Trading Resumption - NVO (PR Newswire)
24.11.17	IIROC Trading Resumption - NVO (PR Newswire)
24.11.17	IIROC Trading Halt - NVO (PR Newswire)
24.11.17	IIROC Trading Halt - NVO (PR Newswire)
21.11.17	Health Canada approves Victoza® as the first and only GLP-1 receptor agonist to reduce the risk of cardiovascular death in patients with type 2 diabetes and established cardiovascular disease. (PR Newswire)
21.11.17	Health Canada approves Victoza® as the first and only GLP-1 receptor agonist to reduce the risk of cardiovascular death in patients with type 2 diabetes and established cardiovascular disease. (PR Newswire)
21.11.17	Sante Canada a approuve Victoza(MD) comme le premier et le seul agoniste du recepteur du GLP-1 pour reduire le risque de deces cardiovasculaire chez les patients atteints de diabete de type 2 et de... (PR Newswire)
21.11.17	Novo Nordisk To Present Updates On R&D And Commercial Strategy (RTTNews)
16.11.17	IIROC Trading Resumption - NVO (PR Newswire)
16.11.17	IIROC Trading Resumption - NVO (PR Newswire)
16.11.17	IIROC Trading Halt - NVO (PR Newswire)
16.11.17	IIROC Trading Halt - NVO (PR Newswire)
15.11.17	Diabetes Community Awakens Important Conversation about Hidden Problem: Hypoglycemia (PR Newswire)
15.11.17	Diabetes Community Awakens Important Conversation about Hidden Problem: Hypoglycemia (PR Newswire)
08.11.17	"Diabetes 360" Survey Shows Patients Want More Than Medicine, Need Emotional Support (PR Newswire)
08.11.17	Chubb Donates Damaged Yves Klein Sculpture to Artist's Archives (PR Newswire)
08.11.17	Canadians' perceptions of ill, wounded and injured veterans have shifted dramatically following Invictus Games; poll (PR Newswire)
07.11.17	TSO3 Reports Record Third Quarter 2017 Results (PR Newswire)
03.11.17	Invitation aux médias - Transfert des patients hospitalisés à l'Hôtel-Dieu vers le nouvel hôpital du CHUM (PR Newswire)
01.11.17	Novo Nordisk 9-Month Profit Rises, Lifts FY17 Forecast; Sees Growth In FY18 (RTTNews)
20.10.17	Dan Hanganu architectes + EVOQ Architecture remportent le concours d'architecture pluridisciplinaire de la Bibliothèque Maisonneuve (PR Newswire)
19.10.17	FDA Blesses 2nd CAR-T Cell Therapy, NVO One Step Away From Approval, AKTX Slumps (RTTNews)
19.10.17	NVO : Semaglutide Gets Positive Vote In Favour Of Approval From FDA Panel (RTTNews)
18.10.17	Novo Nordisk receives positive 16-0 vote from FDA Advisory Committee in favor of approval for semaglutide (PR Newswire)
18.10.17	Mise à jour - Ce qu'il faut savoir avant d'importer des pesticides non homologués pour usage personnel (PR Newswire)
17.10.17	Baylis Medical and Siemens Healthineers co-sponsor physician training for state-of-the art, minimally invasive heart procedure (PR Newswire)
12.10.17	/R E P R I S E -- Avis aux médias - Le ministre Carr tient une conférence de presse au forum Génération Énergie/ (PR Newswire)
11.10.17	Advance voting in federal by-elections begins Friday (PR Newswire)
10.10.17	Selon la Banque CIBC, les petites entreprises canadiennes montrent des signes de fatigue alors que leur confiance s'émousse (PR Newswire)
09.10.17	Atlatsa Resources Corporation Announces Update on Delay in Filing of Unaudited Interim Financial Statements (PR Newswire)
09.10.17	New Drugs Approved In September (RTTNews)
08.10.17	New Flyer Industries Inc. Introduces NFI Parts™ Brand (PR Newswire)
05.10.17	Un exportateur de charbon destiné à la fabrication de l'acier mis à l'amende pour avoir contrevenu à la Loi sur les pêches dans la vallée de la rivière Elk, en Colombie-Britannique (PR Newswire)
05.10.17	IIROC Trade Resumption - HNL (PR Newswire)
03.10.17	The Canadian Medical Hall of Fame honours excellence in health in Canada: announcing the 2018 inductees (PR Newswire)
03.10.17	Striking Blood Sugar Balance is Critical for Canadians Living with Diabetes (PR Newswire)
03.10.17	Striking Blood Sugar Balance is Critical for Canadians Living with Diabetes (PR Newswire)
03.10.17	Atteindre l'équilibre glycémique est essentiel pour les Canadiens atteints du diabète (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	76.62	0.39 %	K V
Part Grp Hldg	1’271.50	0.36 %	K V
Holcim	89.08	0.25 %	K V
Logitech Intl	74.82	-0.05 %	K V
Lonza Grp	540.60	-0.15 %	K V
UBS Group	27.82	-1.24 %	K V
Sika	223.10	-1.37 %	K V
Nestle	74.10	-1.49 %	K V
Swiss Re	129.60	-1.78 %	K V
Givaudan	3’961.00	-2.46 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Novo Nordisk (spons. ADRs)

Aktien Top/Flop

Novo Nordisk Peer Group Nachrichten

Meistgelesene Nachrichten